# Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparison-of-healthcare-resource-utilization-and-costs-in-patients-with-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Emily D. Parker,Eric Wittbrodt,Jeffrey McPheeters,Juan P. Frías |
| Citations | 8 |
| DOI | 10.1111/dom.13502 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2885886636 |
| PMID | 30101553 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Jeffrey McPheeters](https://scholariq.org/researchers/jeffrey-mcpheeters/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.